Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 8
2000 6
2001 3
2002 7
2003 2
2004 4
2006 3
2007 5
2008 13
2009 20
2010 17
2011 5
2012 9
2013 6
2014 18
2015 5
2016 8
2017 8
2018 16
2019 3
2020 7
2021 6
2022 12
2023 6
2024 10
2025 19
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of Clevidipine and Nicardipine for Acute Blood Pressure Reduction in Hemorrhagic Stroke.
Saldana S, Breslin J 2nd, Hanify J, Heierman T, Larizadeh K, Sanchez M, Phipps W. Saldana S, et al. Neurocrit Care. 2022 Jun;36(3):983-992. doi: 10.1007/s12028-021-01407-w. Epub 2021 Dec 13. Neurocrit Care. 2022. PMID: 34904214
Lowering systolic blood pressure (SBP) with an intravenous antihypertensive, such as nicardipine or clevidipine, may reduce the risk of hematoma expansion and rebleeding. Previous studies comparing nicardipine and clevidipine in patients with stroke found no signifi …
Lowering systolic blood pressure (SBP) with an intravenous antihypertensive, such as nicardipine or clevidipine, may reduce the risk …
The Current Role of Clevidipine in the Management of Hypertension.
Xu B, Chen Z, Tang G. Xu B, et al. Am J Cardiovasc Drugs. 2022 Mar;22(2):127-139. doi: 10.1007/s40256-021-00494-6. Epub 2021 Sep 2. Am J Cardiovasc Drugs. 2022. PMID: 34472038 Review.
Unlike nitroglycerin, clevidipine has a limited effect on preload. In contrast to other direct-acting vasodilators, clevidipine has an ultra-short half-life due to metabolism by nonspecific blood and tissue esterases. Clevidipine trials conducted in adult pop …
Unlike nitroglycerin, clevidipine has a limited effect on preload. In contrast to other direct-acting vasodilators, clevidipine …
Clevidipine.
[No authors listed] [No authors listed] Drugs R D. 2002;3(3):190-2. doi: 10.2165/00126839-200203030-00010. Drugs R D. 2002. PMID: 12099165 Review. No abstract available.
Comparison between clevidipine and nicardipine in cerebrovascular diseases: A systematic review and meta-analysis.
Seifi A, Azari Jafari A, Mirmoeeni S, Shah M, Azari Jafari M, Nazari S, Asgarzadeh S, Godoy DA. Seifi A, et al. Clin Neurol Neurosurg. 2023 Apr;227:107644. doi: 10.1016/j.clineuro.2023.107644. Epub 2023 Feb 23. Clin Neurol Neurosurg. 2023. PMID: 36842290
Controlling acute hypertension (HTN) by antihypertensive drugs such as clevidipine and nicardipine can be a highly efficient method of lowering the incidence of CVDs. ...The total volume infused to achieve the goal SBP was significantly lower in the clevidipine grou …
Controlling acute hypertension (HTN) by antihypertensive drugs such as clevidipine and nicardipine can be a highly efficient method o …
Clevidipine for the treatment of severe hypertension in adults.
Nguyen HM, Ma K, Pham DQ. Nguyen HM, et al. Clin Ther. 2010 Jan;32(1):11-23. doi: 10.1016/j.clinthera.2010.01.025. Clin Ther. 2010. PMID: 20171407 Review.

In a multicenter, randomized, double-blind, placebo-controlled study of the efficacy of clevidipine in treating preoperative hypertension, the mean reduction from baseline in mean arterial pressure was 31.2% with clevidipine and 11.2% with placebo (P < 0.001). In

…
In a multicenter, randomized, double-blind, placebo-controlled study of the efficacy of clevidipine in treating preoperative hyperten …
Clevidipine: a review of its use in the management of acute hypertension.
Deeks ED, Keating GM, Keam SJ. Deeks ED, et al. Am J Cardiovasc Drugs. 2009;9(2):117-34. doi: 10.2165/00129784-200909020-00006. Am J Cardiovasc Drugs. 2009. PMID: 19331440 Review.
Clevidipine is highly plasma protein bound and rapidly distributed, and has a low volume of distribution at steady state. ...Clevidipine metabolites are excreted mainly via the urine and feces and the drug has a high mean total blood clearance. ...
Clevidipine is highly plasma protein bound and rapidly distributed, and has a low volume of distribution at steady state. ...Clevi …
Clevidipine: a new intravenous option for the management of acute hypertension.
Ndefo UA, Erowele GI, Ebiasah R, Green W. Ndefo UA, et al. Am J Health Syst Pharm. 2010 Mar 1;67(5):351-60. doi: 10.2146/ajhp080692. Am J Health Syst Pharm. 2010. PMID: 20172984 Review.
PURPOSE: The pharmacology, pharmacokinetics, efficacy, safety, dosage and administration, and place in therapy of clevidipine are reviewed. SUMMARY: Clevidipine is a new lipophilic, short-acting, third-generation dihydropyridine calcium channel blocker (CCB) approve …
PURPOSE: The pharmacology, pharmacokinetics, efficacy, safety, dosage and administration, and place in therapy of clevidipine are rev …
Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.
Kenyon KW. Kenyon KW. Ann Pharmacother. 2009 Jul;43(7):1258-65. doi: 10.1345/aph.1L610. Epub 2009 Jul 7. Ann Pharmacother. 2009. PMID: 19584385 Review.
In clinical trials, clevidipine was well tolerated at infusion rates from 2-32 mg per hour, for up to 72 hours. CONCLUSIONS: Clevidipine is the first intravenous antihypertensive approved by the Food and Drug Administration in nearly a decade. ...
In clinical trials, clevidipine was well tolerated at infusion rates from 2-32 mg per hour, for up to 72 hours. CONCLUSIONS: Clevi …
Comparison of clevidipine vs nicardipine in the treatment of hypertensive urgency and emergency in critically ill patients.
Johnson L, Erdman M, Ferreira J. Johnson L, et al. Am J Health Syst Pharm. 2024 Oct 23;81(21):e668-e676. doi: 10.1093/ajhp/zxae156. Am J Health Syst Pharm. 2024. PMID: 38923443
RESULTS: In total, 182 patients were included in the study (103 receiving nicardipine and 79 receiving clevidipine). Time to goal BP was similar between the groups (35 vs 33 minutes for clevidipine vs nicardipine, respectively; P = 0.37). ...CONCLUSION: Time to goal …
RESULTS: In total, 182 patients were included in the study (103 receiving nicardipine and 79 receiving clevidipine). Time to goal BP …
Clevidipine: a review of its use for managing blood pressure in perioperative and intensive care settings.
Keating GM. Keating GM. Drugs. 2014 Oct;74(16):1947-1960. doi: 10.1007/s40265-014-0313-6. Drugs. 2014. PMID: 25312594 Review.
In small, double-blind trials in patients undergoing coronary artery bypass graft surgery, perioperative clevidipine was noninferior to nitroglycerin, and postoperative clevidipine had similar efficacy to sodium nitroprusside. ...In conclusion, intravenous clevid …
In small, double-blind trials in patients undergoing coronary artery bypass graft surgery, perioperative clevidipine was noninferior …
207 results